Future of Cancer Care
Cancer stem cells (CSCs) are cancer cells (found among tumors or hematological cancers) that possess characteristics related to traditional stem cells, specifically the flexibility to offer a rise to a variety of cells found during a specific cancer sample. CSCs are so tumorigenic (tumor-forming), perhaps in contrast to alternative non-tumorigenic cancer cells. CSCs might generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell varieties. Such cells are hypothesized to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.
- Fluid biopsy
- Cancer Immunotherapy
- Real-time cancer diagnostics
- Radiation Therapy
- Next-generation targeted therapies
- Molecular cancer diagnostics
- Artificial intelligence based therapy design
- In silico trials
- DNA cages
Related Conference of Future of Cancer Care
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
19th International Conference on Human Genomics and Genomic Medicine
Future of Cancer Care Conference Speakers
Recommended Sessions
- Cell Therapy
- Anti-Aging and Regenerative Medicine
- Biobanking
- Biological Tissue Substitutes
- Biomaterials and Bioengineering
- Bone and Cartilage Tissue Engineering
- Cancer Cell Biology
- Cell & Organ Regeneration
- Cell Engineering
- Dental Stem Cells and Tooth Regeneration
- Epigenome and Epigenetic Analysis
- Future of Cancer Care
- Gene Therapy
- Immunology
- Novel Approaches in Guided Tissue Regeneration
- Organ Engineering
- Personalized Medicine
- Stem cells
- Tissue Culture & Preservation
- Tissue Engineering
- Tissue Repair And Regeneration
- Translational Medicine
- Vitrification
Related Journals
Are you interested in
- Advanced Gene Therapeutics - Cell Signaling 2026 (France)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioengineering Therapeutics - Cell Signaling 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Cell Biology - Cell Signaling 2026 (France)
- Cell Culture and Bioprocessing - Cell Signaling 2026 (France)
- Cell Cycle/Proliferation - Cell Signaling 2026 (France)
- Cell Death and Viability - Cell Signaling 2026 (France)
- Cell Science and Stem Cell Research - Cell Signaling 2026 (France)
- Cellular Signaling - Cell Signaling 2026 (France)
- Cellular Therapies - Cell Signaling 2026 (France)
- Clinical Trials and Research in Stem Cell in Cancer Therapy - Cell Signaling 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Epidermis Stem Cell & Cancer Epidemiology - Cell Signaling 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Human Gene Therapy - Cell Signaling 2026 (France)
- Immunotherapy - Cell Signaling 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Molecular Epigenetics - Cell Signaling 2026 (France)
- Nano-Therapy - Cell Signaling 2026 (France)
- Nanotechnology in Stem Cell - Cell Signaling 2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine - Cell Signaling 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Regulatory and Ethical Issues of Therapies. - Cell Signaling 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell in Drug Development - Cell Signaling 2026 (France)
- Stem Cell Therapies - Cell Signaling 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)

